COVID-19 Medicines Optimisation: Specialty Guidance

Summary of COVID-19 medicines guidance: Allergy and immunology

7 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and allergy and immunology conditions.…

Summary of COVID-19 medicines guidance: Anaesthesia and pain

11 November 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and anaesthesia and pain. Our…

Summary of COVID-19 medicines guidance: Cancers

12 November 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and cancers. Our advice is…

Summary of COVID-19 medicines guidance: Cardiovascular system disorders

5 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and cardiovascular system disorders. Our…

Summary of COVID-19 medicines guidance: Critical care

12 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and critical care. Our advice…

Summary of COVID-19 medicines guidance: Diabetes

12 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and diabetes. Our advice is…

Summary of COVID-19 medicines guidance: Endocrine system disorders

15 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and endocrine system disorders. Our…

Summary of COVID-19 medicines guidance: Eyes and vision

18 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and eyes and vision. Our…

Summary of COVID-19 medicines guidance: Family planning

6 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and family planning. Our advice…

Summary of COVID-19 medicines guidance: Gastrointestinal disorders

18 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and gastrointestinal disorders. Our advice…